Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Qianyangyuyin Formula Prevent and Treat for Early Renal Injury in Hypertensive Patients

NCT04078711 is registered in ClinicalTrials.gov with Jiangsu Province Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT04078711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04078711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Qianyangyuyin Formula Prevent and Treat for Early Renal Injury in Hypertensive Patients
Lead sponsor
Jiangsu Province Hospital of Traditional Chinese Medicine
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 10, 2019
Completion date
December 30, 2021
Enrollment
520 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, renal injury